1-15 of 15
Authors: Robert L Murphy
Journal Article
Human Immunodeficiency Virus Type 1 Vpu Inhibitor, BIT225, in Combination with 3-Drug Antiretroviral Therapy: Inflammation and Immune Cell Modulation
The Journal of Infectious Diseases, Volume 223, Issue 11, 1 June 2021, Pages 1914–1922, https://doi.org/10.1093/infdis/jiaa635
Published: 10 October 2020
Journal Article
Erratum to: Changes in Bone Mineral Density After Initiation of Antiretroviral Treatment With Tenofovir Disoproxil Fumarate/Emtricitabine Plus Atazanavir/Ritonavir, Darunavir/Ritonavir, or Raltegravir
The Journal of Infectious Diseases, Volume 221, Issue 12, 15 June 2020, Pages 2083–2084, https://doi.org/10.1093/infdis/jiaa027
Published: 05 February 2020
Journal Article
Changes in Bone Mineral Density After Initiation of Antiretroviral Treatment With Tenofovir Disoproxil Fumarate/Emtricitabine Plus Atazanavir/Ritonavir, Darunavir/Ritonavir, or Raltegravir Get access
The Journal of Infectious Diseases, Volume 212, Issue 8, 15 October 2015, Pages 1241–1249, https://doi.org/10.1093/infdis/jiv194
Published: 05 May 2015
Journal Article
Host Gene Expression Changes Correlating With Anti–HIV-1 Effects in Human Subjects After Treatment With Peginterferon Alfa-2a Get access
The Journal of Infectious Diseases, Volume 205, Issue 9, 1 May 2012, Pages 1443–1447, https://doi.org/10.1093/infdis/jis211
Published: 26 March 2012
Journal Article
Abacavir/Lamivudine Versus Tenofovir DF/Emtricitabine as Part of Combination Regimens for Initial Treatment of HIV: Final Results Get access
The Journal of Infectious Diseases, Volume 204, Issue 8, 15 October 2011, Pages 1191–1201, https://doi.org/10.1093/infdis/jir505
Published: 15 October 2011
Journal Article
Safety, Tolerability, and Mechanisms of Antiretroviral Activity of Pegylated Interferon Alfa-2a in HIV-1- Monoinfected Participants: A Phase II Clinical Trial Get access
The Journal of Infectious Diseases, Volume 201, Issue 11, 1 June 2010, Pages 1686–1696, https://doi.org/10.1086/652420
Published: 01 June 2010
Journal Article
Persistent Abnormalities in Lymphoid Tissues of Human Immunodeficiency Virus–Infected Patients Successfully Treated with Highly Active Antiretroviral Therapy Get access
The Journal of Infectious Diseases, Volume 186, Issue 8, 15 October 2002, Pages 1092–1097, https://doi.org/10.1086/343802
Published: 15 October 2002
Journal Article
Influence of Filgrastim (Granulocyte Colony-Stimulating Factor) on Human Immunodeficiency Virus Type 1 RNA in Patients with Cytomegalovirus Retinitis Get access
The Journal of Infectious Diseases, Volume 186, Issue 7, 1 October 2002, Pages 1013–1018, https://doi.org/10.1086/342956
Published: 01 October 2002
Journal Article
The Pharmacokinetics of Amprenavir, Zidovudine, and Lamivudine in the Genital Tracts of Men Infected with Human Immunodeficiency Virus Type 1 (AIDS Clinical Trials Group Study 850) Get access
The Journal of Infectious Diseases, Volume 186, Issue 2, 15 July 2002, Pages 198–204, https://doi.org/10.1086/341209
Published: 15 July 2002
Journal Article
Safety and Antiviral Activity at 48 Weeks of Lopinavir/Ritonavir plus Nevirapine and 2 Nucleoside Reverse-Transcriptase Inhibitors in Human Immunodeficiency Virus Type 1-Infected Protease Inhibitor-Experienced Patients Get access
The Journal of Infectious Diseases, Volume 185, Issue 5, 1 March 2002, Pages 599–607, https://doi.org/10.1086/339014
Published: 01 March 2002
Journal Article
Indinavir, Nevirapine, Stavudine, and Lamivudine for Human Immunodeficiency Virus–Infected, Amprenavir-Experienced Subjects: AIDS Clinical Trials Group Protocol 373 Get access
The Journal of Infectious Diseases, Volume 183, Issue 5, 1 March 2001, Pages 715–721, https://doi.org/10.1086/318820
Published: 01 March 2001
Journal Article
The Effects of Protease Inhibitor Therapy on Human Immunodeficiency Virus Type 1 Levels in Semen (AIDS Clinical Trials Group Protocol 850) Get access
The Journal of Infectious Diseases, Volume 181, Issue 5, May 2000, Pages 1622–1628, https://doi.org/10.1086/315447
Published: 01 May 2000
Journal Article
Antiviral Effect and Pharmacokinetic Interaction between Nevirapine and Indinavir in Persons Infected with Human Immunodeficiency Virus Type 1 Get access
The Journal of Infectious Diseases, Volume 179, Issue 5, May 1999, Pages 1116–1123, https://doi.org/10.1086/314703
Published: 01 May 1999
Journal Article
Treatment with Amprenavir Alone or Amprenavir with Zidovudine and Lamivudine in Adults with Human Immunodeficiency Virus Infection Get access
The Journal of Infectious Diseases, Volume 179, Issue 4, April 1999, Pages 808–816, https://doi.org/10.1086/314668
Published: 01 April 1999
Journal Article
Prevalence of Measles Antibodies in Asymptomatic Human Immunodeficiency Virus-Infected Adults Get access
The Journal of Infectious Diseases, Volume 164, Issue 5, November 1991, Pages 973–975, https://doi.org/10.1093/infdis/164.5.973
Published: 01 November 1991
